Institutional Sign In

Go

GlaxoSmithKline Czech Republic - Current Liabilities

GlaxoSmithKline CR`s Current Liabilities reached 201 CZK mil in 2017. This is 13.3 % less than in the previous year.

$1.99

Buy Current Liabilities data for GlaxoSmithKline Czech Republic.

$19.99

Buy all data for GlaxoSmithKline Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic CZK mil ... ... ... ... ...             55.7 59.2 51.8 59.7 92.9    
Bayer Czech Republic CZK mil ... ... ...                 306 280 410 426 522    
GlaxoSmithKline Czech Republic CZK mil ... ... ...                 1,747 990 943 656 713    
Merck Czech Republic CZK mil ... ...                   196 187 200 91.9 78.7    
Novartis Czech Republic CZK mil                       1,154 1,205 1,147 1,203 1,380    
Pfizer Czech Republic CZK mil ... ...                   1,835 1,474 1,226 1,212 742    
Roche Czech Republic CZK mil ... ... ...                 1,163 1,231 978 1,168 1,333   ...
Sanofi-Aventis Czech Republic CZK mil ... ... ... ...               2,470 2,603 1,887 1,602 1,838    
Servier Czech Republic CZK mil ... ... ... ... ... ... ... ... ... ... ... ... 48.2 59.1 186 203    
Walmark CZK mil ... ... ...                 558 395 559 735 1,629